GeneralConnection.com ➔ Dictionary
Dictionary Search

actinium

Synonyms

Noun

1. Ac

2. atomic number 89, chemical element, element

Usage
Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice - PR Newswire
Promising Phase 1 Data for Actinium-225 Presented at 2026 ASCO GU - Targeted Oncology
Experimental Novartis radiopharma drug shows promise in early study - Reuters
Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand - BioSpace
Laser spectroscopy and CP-violation sensitivity of actinium monofluoride - Nature
Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting - Yahoo Finance
Phase I PAnTHA Study Evaluates PSMA-Targeted Actinium-225 in mCRPC Patients - Fred Saad - UroToday
Actinium Pharmaceuticals Presents New Radiochemistry Data at SNMMI 2026 Demonstrating That CAR Optimization Improves Tumor Targeting and Pharmacokinetics of Actinium-225 Radioconjugates - PR Newswire
Actinium-225 Demonstrates Safety and Responses in mCRPC - Targeted Oncology
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs - PR Newswire
Exploring the Role of Actinium-225 in Metastatic Castration-Resistant Prostate Cancer - Targeted Oncology
Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development - PR Newswire
Actinium Presents New ATNM-400 Data in KRAS and EGFR Mutant Models at SNMMI 2026 Supporting a Mutation-Agnostic Opportunity In Non-Small Cell Lung Cancer - PR Newswire
Actinium Pharmaceuticals Oral Presentation at SNMMI 2026 Highlights ATNM-400 Overcoming Resistance to All Three Approved Androgen Receptor Inhibitors and Offers Flexible, Well-Tolerated Dosing in Prostate Cancer Models - PR Newswire
Actinium Pharmaceuticals, Inc. Announces Compelling Pan-Tumor Data for ATNM-400 Demonstrating Broad Efficacy Across Prostate, Lung, and Breast Cancer Models at the 2026 American Association of Cancer Research Annual Meeting - PR Newswire
Actinium Pharmaceuticals Announces Three SNMMI 2026 Presentations Highlighting Differentiated Profile of ATNM-400 Across Lung and Prostate Cancer and Radioconjugate Optimization - PR Newswire
Actinium Highlights Transcriptional Reprogramming as a Key Mechanism Underpinning Mutation-Agnostic Activity of Actimab-A in AML at the 2026 American Association of Cancer Research Annual Meeting - PR Newswire
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting - PR Newswire
Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies - PR Newswire
Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeut - PR Newswire
Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposiu - PR Newswire
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC - BioWorld News
Actinium Pharmaceuticals Presents New Data Demonstrating Potent and Durable Efficacy of ATNM-400, a First-in-Class Multi-Tumor Actinium-225 Radiotherapy, at the 32nd Annual Prostate Cancer Foundation Scientific Retreat - PR Newswire
Male contraception startup closes $92.5M Series B; Novartis bets on actinium in Phase 3 - Endpoints News
NorthStar and QSA Global Announce Multi-Year Strategic Partnership to Strengthen Actinium-225 Supply Chain for Targeted Alpha Therapies - PR Newswire
Actinium Pharmaceuticals (NYSE: ATNM) faces NYSE American equity shortfall and listing risk - Stock Titan
Actinium Announces Superior Anti-Tumor Activity of ATNM-400 in Lung Cancer Compared to the Leading First, Second and Third-Line Approved EGFR Mutant Therapies and Mechanistic Synergy with Osimertinib at the AACR-NCI-EORTC International Confer - PR Newswire
Actinium Pharmaceuticals, Inc. to Highlight ATNM-400 Data in Hormone-Resistant and HER2-Resistant Breast Cancer at the 2025 San Antonio Breast Cancer Symposium, Expanding Pan-Tumor Profile Across Three Solid Tumor Indications - PR Newswire
Mayo Clinic researchers investigate novel radiopharmaceutical therapy for breast cancer - Mayo Clinic
TerraPower Commits $450M To Build Radioisotope Production Plant - BioSpace
Niowave kicks off construction of $75M radiopharmaceutical isotope plant in Michigan - Fierce Pharma
TerraPower announces second Ac-225 production facility - American Nuclear Society -- ANS
Niowave and Novartis Enter Global Actinium-225 Supply Agreement to Advance Next-Generation Cancer Therapies - PR Newswire
NorthStar and QSA Global sign multi-year partnership to secure actinium-225 supply chain - Manufacturing Chemist
NorthStar Secures FDA Acceptance of Drug Master File for No-Carrier-Added Actinium-225 - Business Wire
Pennsylvania to house new actinium-225 manufacturing facility - European Pharmaceutical Review
The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet - TMX Newsfile
UCLA Health launches novel clinical trial for recurrent prostate cancer - UCLA Health
Actinium Recruits Oncology Veteran Steffen Heeger as CMO to Advance Radiotherapy Pipeline - citybiz
TerraPower Isotopes Invests $450M in Actinium-225 Production Facility - Oncodaily
Novartis advances actinium-based cancer drug after promising trial data - Mugglehead Investment Magazine
Cardinal Health Deepens Actinium-225 Role As Board Leadership Shifts - Yahoo Finance
Actinium Pharmaceuticals Presents New Radiochemistry Data at SNMMI 2026 Demonstrating That CAR Optimization Improves Tumor Targeting and Pharmacokinetics of Actinium-225 Radioconjugates - Barchart.com
Niowave, fresh from Novartis deal, starts building $75M radioisotope plant - BioSpace
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year? - Yahoo Finance
Actinium presents radiochemistry data on antibody ratio optimization - Investing.com
Actinium Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
BIOEMTECH and NorthStar Medical Radioisotopes Announce Strategic Supply Agreement for Actinium-225 to Support Preclinical Radiopharmaceutical Research - Business Wire
AstraZeneca locks in long-term actinium-225 supply with Niowave - The Pharma Letter
ProTACT Trial Investigates Next-Generation PSMA-Targeted Alpha Therapy for mCRPC - Aaron Hansen - UroToday
High-energy resolution X-ray spectroscopy reveals bonding characteristics of La - Nature
Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice - Barchart.com
Niowave breaks ground on $75 million facility to expand Actinium-225 production - DOTmed
Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies - PR Newswire
TerraPower Isotopes, PanTera expand partnership to increase actinium-225 production - DOTmed
Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development - Barchart.com
Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice – Company Announcement - FT.com - Financial Times
Jeri Kim: Thrilled to Join Actinium Pharmaceuticals as VP, Head of Solid Tumor Clinical Development - Oncodaily
SK biopharmaceuticals secures European supply of actinium-225 through deal with Germany's Eckert & Ziegler - koreabiomed.com
Novartis taps Niowave for long-term supply of radiopharmaceutical isotope - Fierce Pharma
Expanded Actinium‑225 Capacity And Higher EPS Guidance Could Be A Game Changer For Cardinal Health (CAH) - Yahoo Finance
Why Is Actinium Pharmaceuticals Stock Rising Today? - Stocktwits
Actinium presents preclinical data on ATNM-400 for lung cancer - Investing.com
Ac-PSMA: The Truth Should be Told! "Presentation" - Matthias Eiber - UroToday
Phase 1 Trial of an Actinium-Labeled KLK2-Targeting Antibody for mCRPC - Michael Morris - UroToday
TerraPower Isotopes Breaks Ground on World's Largest Actinium-225 Manufacturing Facility in Philadelphia - PR Newswire
SK Biopharmaceuticals Advances Actinium-Based RPT Cancer Drug Into Clinical Trials - thelec.net
TerraPower Isotopes announces cGMP manufacturing facility - PR Newswire
Actinium Pharmaceuticals Presents New Radiochemistry Data at SNMMI 2026 Demonstrating That CAR Optimization Improves Tumor Targeting and Pharmacokinetics of Actinium-225 Radioconjugates – Company Announcement - FT.com - Financial Times
Niowave Extends Actinium 225 Supply Agreement With AstraZeneca To Support Next Generation Cancer Therapies - BioPharma APAC
Gates-backed TerraPower Isotopes blueprints $450M plant to supply next wave of radiopharmaceuticals - Fierce Pharma
Niowave Invests $75 Million in Actinium-225 Production Plant Following Deals with AstraZeneca and Novartis - geneonline.com
Actinium presents preclinical data on ATNM-400 for lung cancer By Investing.com - Investing.com South Africa
Actinium Pharmaceuticals presents preclinical data for ATNM-400 - Investing.com
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs - Barchart.com
Actinium Pharmaceuticals - Receives Two Canadian Patent Allowances For Actimab-A And Iomab-Act Programs - TradingView
TerraPower Isotopes plans Philadelphia facility to expand actinium-225 supply - DOTmed
Actinium Pharmaceuticals Oral Presentation at SNMMI 2026 Highlights ATNM-400 Overcoming Resistance to All Three Approved Androgen Receptor Inhibitors and Offers Flexible, Well-Tolerated Dosing in Prostate Cancer Models - The Malaysian Reserve
Actinium Presents Data Supporting Paradigm Changing Potential of ATNM-400 in Prostate Cancer Demonstrating Its Superior Efficacy and Improved Survival in Treatment Resistant Tumor Models versus Pluvicto and ARPI Therapy, and Also Enhanced Efficac - PR Newswire
Actinium presents radiochemistry data on antibody ratio optimization By Investing.com - Investing.com South Africa
Why is Actinium Pharmaceuticals stock rising today? - MSN
Cancer drug developers get more Actinium-225 as Cardinal Health expands - Stock Titan
Niowave to supply actinium-225 to Novartis under long-term agreement - DOTmed
TerraPower Isotopes Breaks Ground on Major Actinium-225 Facility in Philadelphia - citybiz
TerraPower to build actinium-225 manufacturing site in Pennsylvania - megaproject.com
First Patient With Breast Cancer Dosed With Novel Radioactive Medicine - Cure Today
Actinium presents preclinical data on AML drug at AACR meeting - Investing.com
SK Biopharm secures Actinium-225 supply in Europe with Eckert & Ziegler deal - The Korea Herald
NorthStar Medical Radioisotopes Confirms Successful Routine Commercial-scale Ac-225 Production - BioSpace
SNMMI 2025: How About Actinium-225? - UroToday
Actinium to present preclinical data at AACR meeting April 21 - Investing.com
Actinium presents preclinical data on ATNM-400 for lung cancer By Investing.com - Investing.com Australia
Former Southwest Philly refinery site will become home to nuclear life science facility - WHYY
Preclinical data show promise of ATNM-400 for prostate cancer - Urology Times
New radioactive isotope therapies promise more targeted attacks on cancer - Science | AAAS
Actinium Pharmaceuticals - receives two Canadian patent allowances for Actimab-A and Iomab-Act programs - marketscreener.com
Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer - Mayo Clinic News Network
Actinium Pharmaceuticals, Inc. (ATNM) announced that two patent applications related to its Actimab-a and Iomab-Act projects have been granted by the Canadian Intellectual Property Office. - Bitget
Actinium presents preclinical data on ATNM-400 for lung cancer By Investing.com - Investing.com Canada
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies - Investing News Network
Foreign Language Equivalents
Foreign Language Equivalents of 'actinium'
Language Equivalent   Language Equivalent
French actinium    Spanish
Misspellings - Typos
atinium,   actinuum,   actimium,   actinnium,   sctinium,   avtinium,   actnium,   actiinum,   actiniym,   actiium,   actiniim,   actiniumm,   acrinium,   acyinium,   actinim,   acinium,   catinium,   actiniu,,   atcinium,   actinuim,   actiinium,   acttinium,   ctinium,   actiniuum,   actiniium,   actunium,   axtinium,   actiniu,   actinimu,   acctinium,   actinum,   actinoum,   actiniun,   actonium,   actibium,   aactinium,   acitnium,   actniium
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z